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Abstract

DNA methylation is one of the key epigenetic modifications of DNA that results from the enzymatic addition
of a methyl group at the fifth carbon of the cytosine base. It plays a crucial role in cellular development,
genomic stability and gene expression. Aberrant DNA methylation is responsible for the pathogenesis of
many diseases including cancers. Over the past several decades, many methodologies have been developed to
detect DNA methylation. These methodologies range from classical molecular biology and optical
approaches, such as bisulfite sequencing, microarrays, quantitative real-time PCR, colorimetry, Raman
spectroscopy to the more recent electrochemical approaches. Among these, electrochemical approaches offer
sensitive, simple, specific, rapid, and cost-effective analysis of DNA methylation. Additionally, electrochemical
methods are highly amenable to miniaturization and possess the potential to be multiplexed. In recent years,
several reviews have provided information on the detection strategies of DNA methylation. However, to date,
there is no comprehensive evaluation of electrochemical DNA methylation detection strategies. Herein, we
address the recent developments of electrochemical DNA methylation detection approaches. Furthermore,
we highlight the major technical and biological challenges involved in these strategies and provide suggestions
for the future direction of this important field.
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Abstract
DNA methylation is one of the key epigenetic modifications of DNA that results from the
enzymatic addition of a methyl group at the fifth carbon of the cytosine base. It plays a
crucial role in cellular development, genomic stability and gene expression. Aberrant DNA
methylation is responsible for the pathogenesis of many diseases including cancers. Over the
past several decades, many methodologies have been developed to detect DNA methylation,
which range from classical molecular biology and optical approaches, such as bisulfite
sequencing, microarrays, quantitative real-time PCR, colorimetry, Raman spectroscopy to the
more recent electrochemistry-based approaches. Among these, electrochemistry-based
approaches offer sensitive, simple, specific, faster, and cost-effective analysis of DNA
methylation. Additionally, electrochemical methods are highly amenable to miniaturization
and possess the potential to be multiplexed. In recent years, several reviews have provided
information on the detection strategies of DNA methylation. However, to date, there has been
no comprehensive one solely discussing electrochemistry based DNA methylation detection
strategies. Herein, we address the recent developments of electrochemical DNA methylation
detection approaches. Furthermore, we also highlight the major technical and biological
challenges involved in these strategies and provide suggestions for the future direction of this
important field.
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Hypermethylation,

1. Introduction
DNA methylation is the covalent addition of a methyl group to the fifth carbon of the
cytosine base in the CpG dinucleotide of DNA (Bird, 2002). This important epigenetic
alteration converts cytosine (C) to methylcytosine (5mC) keeping the original DNA
sequences unchanged (Bird 2002; Tucker 2001). It plays important roles in various cellular
regulatory pathways, such as gene expression and regulation, maintaining genomic stability,
X chromosome inactivation and mammalian cell development (Constancia et al., 1998; Jones
and Gonzalgo, 1997; Mohandas et al., 1981; Robertson and Jones, 2000). Thus, alteration in
DNA methylation can result in different genetic and physiological anomalies, causing a
number of diseases including neurodegenerative disorders, cardiovascular diseases and
cancers (Ehrlich, 2002; Esteller, 2005; Jones and Gonzalgo, 1997).
A high level of methylated versus unmethylated DNA sequences is known as
hypermethylation, whereas a low level of methylated compared to unmethylated DNA is
known as hypomethylation. Early studies on DNA methylation have established a hypothesis
that abberant DNA hypermethylation of the promoter region of tumor suppressor genes can
initiate cancer by silencing these genes. Hypermethylation can also deactivate homebox
genes, which results in abnormal morphological development, also causing cancers (Ehrlich,
2002; de Caceres et al., 2004; Jones and Gonzalgo, 1997). Hypomethylation spanning a large
portion of the genome, is also actively involved in cancer development (Ehrlich, 2009). DNA
hypomethylation can lead to abrupt mitotic recombination, reactivation and subsequent
integration of DNA at random sites of the genome, leading to mutagenesis and genomic
instability resulting in cancer (Ehrlich, 2002; Taleat et al., 2015). Due to the strong
pathological effects of alterations in methylation levels, DNA methylation status has become
an important biomarker for the prognosis and diagnosis of diseases, including cancers.
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Over the past few decades, considerable attention has been dedicated to develop
effective methodologies to analyze DNA methylation for both research and diagnostic
purposes (Herman et al., 1996; Singer-Sam et al., 1990; Hernandez et al., 2013; Taleat et al.,
2015; Zhang et al., 2015b; Islam et al., 2016). The most widely used DNA methylation
detection technique is bisulfite sequencing (Frommer et al., 1992). This techniques consists
of bisulfite conversion of DNA followed by polymerase chain reaction (PCR) amplification
and sequencing of the target methylation site. A range of modified PCR and sequencing
approaches have been adopted with bisulfite conversion based approaches for DNA
methylation analysis, for instance; methylation specific PCR (MSPCR) (Herman et al., 1996),
quantitative MS-PCR (Hibi et al., 2011), real-time PCR (BonDurant et al., , 2011),
methylight (Eads et al., 2000), methylation-sensitive high resolution melting (MS-HRM)
(Wojdacz and Dobrovic, 2007), methylation-sensitive single nucleotide-primer extension
(MS-SnuPE) (Gonzalgo and Jones, 1997), next generation sequencing (NGS) (Taylor et al.,
2007) and reduced representation bisulfite sequencing (RRBS) (Meissner et al., 2005).
Conventional analytical methods such as high performance liquid chromatography (HPLC),
high performance capillary electrophoresis (HPCE) and mass spectroscopy (MS) have also
been used for accurate detection of 5mC (Friso et al., 2002; Tost and Gut, 2006). Despite the
accuracy of detection using HPLC, HPCE and MS methods, their routine clinical use is
limited by the requirement for large amounts of input DNA, and sophisticated instruments,
the longer analysis time and, low sensitivity associated with HPLC, HPCE and MS methods.
In recent years, other advanced detection techniques have also been extensively developed.
These include combined bisulfite restriction analysis (COBRA) (Xiong and Laird, 1997),
microarray based DNA methylation profiling (Gao et al., 2005; Yan et al., 2001), surface
enhanced Raman spectroscopy based assays (Wang et al., 2015a, 2016a), fluorescence based
biosensors (Duan et al., 2010; Ma et al., 2015; Taleat et al., 2015; Wang et al., 2009),
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colorimetric assays (Ge et al., 2012; Wee et al., 2015a), surface plsmon resonance based
assays (Carrascosa et al., 2014; Sina et al., 2014a) and quartz crystal microbalance (QCM)
assay (Taleat et al., 2015).These techniques are also disadvantaged by their multi-step timeconsuming analytical procedures,

the requirement for large amounts of input DNA,

hazardous radiolabeling and/or expensive biological molecules, such as antibodies. Hence the
development of a cost-effective, convenient and accurate method for analyzing DNA
methylation status is important for medical research.
To overcome the major drawbacks of conventional methods for DNA methylation
analysis, much attention has been given in developing new strategies based on
electrochemistry and photoelectrochemistry (Labib et al., 2016; Lee et al., 2016; Liu et al.,
2016; Taleat et al., 2015; Koo et al., 2014a; Sina et al., 2014b; Koo et al., 2014b; Dai et al.,
2013; Sato et al., 2010). In comparison to the other detection approaches, electrochemistry
based techniques are relatively simple, inexpensive, rapid, selective, sensitive and
independent of radioactive substrates. Moreover, this technique requires only a low volume
of sample. The electrochemical detection instrument is amenable to miniaturization (e.g. a
small potentiostat that is only a few millimeters in size is commercially available), which is
highly suitable for point-of-care settings.
In recent years, DNA methylation detection techniques have been reviewed by
various groups. Taleat and colleagues reviewed recent nanotechnology based strategies (till
2014) (Taleat et al., 2015). Shanmuganathanet et al. (2013) and Zhang et al. (2015b)
comprehensively discussed conventional DNA methylation techniques, whereas Hernándezet
al., (2013) and Islam et al., (2016) focused solely on the PCR based and optical techniques.
To the best of our knowledge, electrochemical techniques for DNA methylation analysis have
not been comprehensively reviewed. Herein, we summarize the recent advances in
electrochemical methylation detection strategies and discuss the challenges involved in
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electrochemical methylation sensor along with our perspectives on future progress in this
field.

2. Diagnostic and prognostic significance of DNA methylation
As one of the most common epigenetic signalling tools, DNA methylation, mainly
occurs at the cytosine bases that have been used for regulating gene expression negatively
(Phillips, 2008; Qureshi et al., 2010). A family of DNA methyl transferases (Dnmts)
catalyses the DNA methylation process. The de novo Dnmts, Dnmt3a and Dnmt3b are
responsible for transferring a methyl group to unmodified DNA, whereas during replication,
Dnmt1 known as the maintenance Dnmt, copies the methylation pattern onto the newly
synthesized daughter strand from parental DNA (Fig. 1) (Moore et al., 2013).

(please put Figure 1 here)

In 1983, Feinberg and Vogenstein, first showed the relationship between DNA
methylation and cancer that the cancer cell of the genomes are hypomethylated compared to
their respective normal cells (Feinberg and Vogelstein, 1983). Later on, Greger et al., (1989)
showed that hypermethylation also occurs at the 5' end of retinoblastoma gene in tumor
which is usually unmethylated in normal cells. Further, Ohtani-Fujita et al., (1993) and
Herman et al., (1994) correlated the methylation of the tumour-suppressor genes with their
actual silencing in cancer. Fig. 1 represents a region of a normal cell and progression on
becoming a tumor cell. In tumor cells, hypomethylation occurs within the heterochromatin
structure, and contributes to genomic instability and the de novo methylation in CpG islands,
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resulting in transcriptional silencing of growth-regulatory genes, which are common early
events in tumorigenesis (Robertson, 2005).
In mammalian genomes, around 85% CpG dinucleotides are distributed across the
genome (scattered), while nearly 40% are in repetitive sequences. In a normal cell, these
CpGs are largely hypermethylated reflecting that the genome is stable. On the other hand,
these CpGs are hypomethylated in cancer cells, indicating a higher level genomic instability
(Bird, 1992; Baylin and Ohm, 2006; Gaudet et al., 2003). The remaining 15% of CpGs exist
as clustered form --“CpG island”. Around 40–50% of human genes have CpG islands, within
or near to the promoter region which reflects that DNA methylation is involved in the control
of transcription of these genes (Zhu and Yao, 2009). Moore et al., (2008) showed that the
hypomethylation state of circulating peripheral blood cells is tightly associated with an
increase in risk of human bladder cancer, and that such cancer cells can be detected early by
using the global hypomethylation state. Moreover, cancer genes are elevated with the
promoter CpG islands containing genes and it has been associated with inactivation of tumor
suppressor genes as well as oncogenic transformation. Thus aberrant methylation of CpG
islands of genes can play roles in tumor formation and progression and, detection of such
alternation in DNA methylation play significant roles in the detection of pre-malignant or
early stage of disease (Montavon et al., 2012). Besides, aberrant DNA methylation provides a
binary signal, where the presence of methylation indicates the presence of tumor cells (Barton
et al., 2008). Caceres et al. (2004) showed that analysis of tumor-specific hypermethylation in
serum DNA enhances the early detection of ovarian cancer. In this approach,
hypermethylation is observed in the matched serum DNA of 41 of 50 patients (with 82%
sensitivity) where 13 of 17 cases of stage I disease. In contrast, no hypermethylation was
observed in normal samples collected from 40 control women (100% specificity). The study
suggested that in ovarian cancer, promoter hypermethylation is a common and early event
8

that can be detected in the serum DNA from patients with stage IA or B tumors (at early
localized stage of cancer).
Apart from its diagnostics roles, DNA methylation has been reported to be a good
indicator to track tumor prognosis. Milani et al., (2010) first reported the prognostic roles of
DNA methylation profiling for childhood acute lymphoblastic leukaemia samples. In this
study, they measured DNA methylation level of 401 patients and 1320 CpG sites that helped
to classify the patients into acute lymphoblastic leukaemia sub-types. In 2005, Chan et al.,
(2005) reported the positive prognostic potential of DNA methylation in ovarian cancer
where it was shown that hypermethylation of 18S and 28S rDNA methylation levels were
higher in patients with long progression-free survival versus patients with short survival.
Moreover, Serum RASSF1A and APC promoter 1A hypermethylation is a frequent
epigenetic event in early operable gastric cancer patients (Balgkouranidou et al., 2015). They
were examined 73 gastric cancer samples, of them the APC promotors for 61 patients and
RASSF1A promoters for 50 patients found to be methylated around 93.6% and 68.5%
respectively, but none of the healthy control samples. Also, Tang et al. (2011) reported the
strong evidence of promoter hypermethylation of SFRP2 in the tissue, fecal and serum
samples of patients with colorectal carcinoma which was significantly linked with poor
differentiation grade, lymphonode metastasis status, TNM stage and shorter overall survival.
In addition, methylation of SHOX2 in lung cancers (Dietrich et al., 2012), FHIT promoter
methylation in ESCC (Lee et al., 2006), PITX2 promoter methylation in prostate (Dietrich et
al., 2013) and breast carcinomas (Nimmrich et al., 2008) were correlated with patient
prognosis. Thus, DNA methytlation has the potential to be used as a therapeutic biomarker as
well. For instance, Teodoridis et al., (2005) showed that methylation of the
BRCA1, GSTP1 and MGMT genes responsible for DNA repair/drug detoxification is
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associated with improved response to chemotherapy in late stage cancer patients with
epithelial tumor.

3. Electrochemical detection techniques of DNA methylation
In electrochemical detection of DNA methylation, generally a recognition element
(e.g. antibody, enzymes, oligonucleotide probe etc.) interacts with the target sequence to
selectively recognise the methylated region present in that sequence, then an electroactive
signal transducer is incorporated to obtain measurable electrochemical signal to quantify the
level of DNA methylation (Labib et al., 2016). Mostly, the detection is read via voltametric
techniques (i.e., cyclic voltammetry (CV), linear sweep voltammetry, differential pulse
voltammetry (DPV), square wave voltammetry (SWV) and stripping voltammetry),
amperometry and impedimetric methods. Among these readouts, voltametric techniques,
especially CV and DPV, are generally preferred (Topkaya et al. 2016). Due to the versatile
ability of electrochemical sensors to detect DNA methylation with high sensitivity, over the
past several years, a number of electrochemical assays have been developed. They can
broadly be categorized into three main types based on their assay construction strategies: (i)
enzymatic reaction and amplification, (ii) electroactive species, and (iii) affinity interaction of
DNA nucleobases based assays. These assays are discussed in the remaining sections of the
paper.

3.1. Electrochemical DNA methylation assays based on enzymatic reaction and
amplifications

3.1.1. Direct electrochemical oxidation of 5mC
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The electrochemical activity (i.e., oxidation) of 5mC and other nucleobases can be
used to quantify the amount of 5mC present in a target DNA sequence. Since each base poses
a definite oxidation potential at most of the conventional electrodes (i.e., carbon, gold or
indium tin oxide (ITO)), the magnitude of the oxidation current of 5mC obtained at these
electrodes gives the amount of 5mC present in a target DNA (Kato et al., 2013; Brotons et al.,
2016a; Brotons et al., 2016b). The direct oxidation based quantification is suffered by the two
difficulties. First, the oxidation peak potential of C and 5mC are extremely difficult to
identify due to their similar molecular structure and electrochemical properties. Second, the
oxidation potential of T is almost the same as that of 5mC at most of the unmodified
electrode materials, which results in a great interference for the recognition and detection of
5mC (Wang et al., 2010). One of the best ways to avoid these challenges would be to develop
new electrode materials with a wider potential window and higher electrode activity (Ivandini
et al., 2007, Wang et al., 2013, March et al., 2015). In 2007, Einaga and colleagues reported
an electrochemical method based on a boron-doped diamond (BDD) thin-film electrode,
which showed a wider potential window in acid medium (i.e., low pH) and successfully
detected 5mC in fish sperm DNA samples. In this method, a reverse phase HPLC separation
was incorporated with BDD based electrochemical detection to achieve highly resolved 5mC
peak (Ivandini et al., 2007).
In response to achieve electrode materials with a wider potential window and higher
electrode activity, Kato et al. have developed a nanocarbon film electrode where electron
cyclotron resonance (ECR) was used to deposit sp2 and sp3 carbon mixture on a sputtered
nanocarbon film to produce high electrode stability (Kato et al., 2008). In this method, a
significant potential difference (130-150 mV) between 5mC and C oxidation peaks was
observed from the background-subtracted square wave voltammetric data. They also
demonstrated that despite having large potential window, BDD film based electrodes
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relatively lower current responses for 5mC and C (i.e., low electrode activity). This is due to
the excess amount of sp3 carbon content present on the diamond surface of BDD (DNA
bases prefer to adsorb more on sp2 or sp2-sp3 hybridized carbon surface due to Π- Π
interactions) (Kato et al., 2008). However, this method was only tested in a short synthetic
DNA sequence and one obvious disadvantage is the associated false background peaks
resulting from the bases hidden inside the helical structure of DNA.
To reduce the background peaks, the Kato et al. proposed a unique assay for
quantifying 5mC where DNA sequences were cut into single bases by restriction
endonuclease followed by their electrochemical oxidation (Kato et al., 2011). In this assay, a
long CpG oligonucleotide was treated with restriction endonuclease P1 which formed an
identical mononucleotide 50-dNMP (20-deoxy-ribonucleoside-50-monophosphate) (Fig. 2
(i)). The direct oxidation of both 5-mC and C was measured on a sputtered nanocarbon film
electrode using square wave voltammetry. In comparison to the other P1 digestion free
sample, several-fold enhanced result was observed in terms of sensitivity and dynamic
concentration range. Because it only requires simple digestion of DNA sample followed by
direct electrochemical oxidation on a device that can easily be manufactured at low cost, this
method has significant potential in real biological and clinical applications.
Although the direct oxidation based detection of 5mC at modified electrodes is
inherently sensitive, they are limited by the use of background subtraction of voltammetric
signal of known DNA sequences (i.e., bases) to discriminate 5mC peaks from that of T. This
could create a significant challenge for an unknown sample (if the DNA sequence is
unknown, the quantification of 5mC could be influenced with the overlapped T). This
challenge have been addressed by using an innovative subtraction formula based on the
principle of complementary base pairing in DNA sequence, as described by Wang et al.
(2010). They had developed a simple method for the detection of DNA methylation using
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direct electrochemical oxidation at a multiwalled carbon nanotubes and enzyme- modified
glassy carbon electrode. This method also rely on the background subtraction method.
However, as the molar concentration of A is equal to the molar concentration of T (as they
are complementary to each other in an unknown DNA sequence), by subtracting the
voltammetric signal of A from overlapped 5mC and T, the signal of T in a DNA sample was
achieved, which allowed direct quantification of 5mC level in the unknown target DNA
samples (see, typical responses in Fig. 2(ii)). They also extended this work to detect DNA
methylation using over-oxidized polypyrrole (PPyox) directed multiwalled carbon nanotubes
based electrodes (Wang et al., 2013). In recent years, in order to achieve good resolution
between oxidation peaks of 5mC and C, several other direct electrochemistry approaches
based on graphene, graphite, and carbon nanotube-modified electrodes have also been
reported (Zhang et al., 2013, Wang et al., 2015c, Wang et al., 2016b, Meng et al., 2013,
Brotons et al., 2013).

(Please insert Fig. 2 here)

3.1.2. Restriction enzyme digestion based assays
Recent demonstrations have shown that restriction enzyme digestion can be used in
electrochemical detection of DNA methylation by two ways. First, direct oxidation of
restriction enzyme digested DNA bases at modified or unmodified electrodes (e.g., 5mC and
other bases at nanocarbon flim electrode (Kato et al, 2011), as discussed above). Second,
selective recognition of 5mC using methylation sensitive restriction enzymes such as HpaII
and Not I (Dai et al., 2012). In these assays, as their name implies, methylation sensitive
restriction enzymes cannot cleave the methylated DNA sequences, while it can fully digest
the unmethylated DNA sequences (Cedar et al., 1979; Quint and Cedar, 1981). This was
13

experimentally demonstrated by Hou et al. (2013), where regional methylation of p16Ink4a
tumor suppressor gene was electrochemically quantified. In this method, genomic DNA was
first treated with MseI restriction enzyme to get DNA fragments with cleaved ends, which
were then ligated with unphosphorlylated linkers (in this case, they act as universal PCR
primers). The ligated DNA was further digested with the methylation sensitive restriction
endonuclease BstUI followed by PCR amplification. This results two sets of products: (i)
unmethylated DNA which was not amplified due to BstUI digestion (ii) amplified product of
methylated DNA as methylated DNA was unaffected by BstUI. The amplified products were
then detected by using conventional hybridization technique. CV and SWV voltammetric
techniques were used to read the methylation information in the presence of a
[Co(phen)3](CIO4)3 intercalator.
One of the major complications of this method is the use of PCR amplification. In
order to avoid the PCR amplification step, Dai et al. (2013) have proposed an enhanced
digestion based electrochemical assay, where an oligonucleotide capture probe-functionalised
gold electrodes were used to specifically hybridized both methylated and unmethylated DNA
target. Methylene blue (MB), an electrochemically active dye, was then intercalated in the
surface-bound dsDNAs due to the interaction between guanine residues and MB. These
electrodes were then treated with the methylation sensitive restriction enzyme HpaII, which
precisely cleaved the unmethylated DNA leaving 5mC based dsDNA unaffected, resulting in
a partial loss of intercalated MB present in the unmethylated dsDNA sample. This offers a
significant reduction in the voltammetric current in compare to that of the methylated
counterpart. By measuring the relative current changes for methylated and unmethylated
samples, the degree of DNA methylation was calculated.
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3.1.3. DNA methyltransferase activity based assays
As discussed in section 2, the relative level of methylation in whole genome or in a
specific gene is regulated by the DNA methyltransferase (Mtase) enzyme. An overexpression of DNA MTase triggers aberrant DNA methylation, that facilitates the tumor
progression through the inactivation of CpG island methylation mediated gene (Issa et al.,
1993; Vertino et al., 1996; Robertson, 2001). For instance, in comparison to non-tumorgenic
cell lines, MTase level was reported to be higher in tumorgenic cell line. Additionally, Issa et
al. (1993) reported that colon tumorgenesis is also accompanied by the increased expression
of this enzyme. Therefore, DNA methylation can be analyzed indirectly via assaying DNA
MTase activity towards a target DNA. In recent years, much attention has been focused on
developing electrochemical methods for measuring MTase activity (Li et al., 2015; Liu et al.,
2015; Liu et al., 2016b). For example, Liu et al., (2011) reported an electrochemical assay for
the detection of DNA methylation and the activity of MTase enzyme at specific CpG
methylation sites. In this method, an ferrocene acetic acid (FcA) level was used to conjugate
with the hybrid dsDNA. This labeled DNA was then treated with MTase M.SsI enzyme
followed by a methylation sensitive restriction enzyme HpaII endonuclease treatment. This
enzyme treatments cleaved the portion of unmethylated dsDNA between adjacent cytosine
causing the loss of FcA labels and offering a reduced voltammetric signal of FcA. On the
other hand, since HpaII cannot exert its activity in presence of 5mC, the FcA labelled
methylated dsDNA was not cleaved thereby, producing a higher voltammetric signal.
Therefore, the voltammetric current generated is directly related with the level of methylation
and MTase activity. Althogh this method is helpful for genomic DNA methylation analysis,
the sensitivity is relatively lower compared to other reported methyltransferase assays.
Furthermore, it is also limited by the use of FcA labeling.
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In an another assay, Muren et al., (2013) had used an innovative strategy with a
multiplexed

platform

for

detecting

both

human

(Dnmt1)

and

bacterial

(Sssl)

methyltransferase activity. In this assay, a multiplexed chip consisting of sixteen electrodes
was taken and divided into four quadrates. Each quadrate was modified with different DNA
substrates (containing methylation site 5′-CG-3′ of humans) and treated with a unique MTase
enzyme and each electrode was also combined with a redox probe. The treatment of
electrodes with MTase (active form) made the sites (5′-CG-3′) methylated. The methylated
CpG sites protect the DNA from cutting by restriction enzyme treatments. Therefore the
redox signal from the probe (as DNA was intact and contained redox probe) was retained and
offered signal-on state. While without the activity of MTase (due to the presence of inactive
form of MTase), unmethylated DNA was easily cut down by restriction enzyme and resulting
in the loss of redox probe, thereby producing lower redox signal (i.e., the near complete
disappearance of redox signal). This method is able to compare up to four types of different
DNA methylation targets and four MTase activities on a single platform (Fig. 3(i)).
Due to the ability of being a powerful tool of detecting aberrant DNA methylation,
MTase activity based assay has been a subject of many significant studies to assist disease
diagnosis and prognosis. Most of these methods were largely rely on physical (i.e.,
nanomaterial based), enzymatic, and non-enzymatic amplification processes (He et al., 2011;
Wang et al., 2012; Baek et al., 2013; Xu et al., 2013; Wang et al., 2015d; Zhang et al., 2015a;
Zhang et al., 2016; Hong et al., 2016). For example, Zhang et al. ( 2016) had developed a
method for detecting DNA methylation via measuring M.SssI MTase avitivity using AuNPs
as primary signal amplification element coupled with non-enzymatic hybridization chain
reaction (HCR) amplification and methylation sensitive restriction enzyme digestion steps. In
this method, initially AuNPs and gold electrode were modified with P3 and C1 probes
respectively. A linker probe (L2) was assembled on to the electrode surface by hybridization
16

between C1 and L2 probes, resulting a dsDNA containing a special sequence of 5' -CCGG-3'.
P3 probe-modified AuNPs (DNA AuNPs) were then attached with the electrode surface via
sandwich hybridization (L2 contains two complementary parts which are able to hybridize
with C1 and P3) followed by the addition of two HCR hairpin probes (H4 and H5; H4 was
designed to have a complementary region to H5 and an overhanging 5´- ends to hybridize
with P3). This forms a large amount of dsDNA on the electrode surface. In the subsequent
step, RuHex redox molecule was used to neutralized the electrode surface (this results
enormous RuHex tags on the electrode surface). Under the unmethylated condition, that is
when 5'-CCGG-3' present in sandwiched dsDNA, it could be recognized, cleaved by
endonuclease HapII, and further digested by exonuclease ExoIII enzymes. This results no
DNA-AuNPs on the electrode surface, and hence no mimic-HCR occurred so that the
voltammetric current from RuHex had no obvious effect. However, when the cleavage was
blocked after the methylation of M.SssI MTase (i.e., 5'-CCGG-3' sequences is methylated),
DNA-AuNPs on the Au-electrode surface could induce mimic-HCR, resulting in high DPV
current.

(Please insert Fig. 3 here)

Jing et al. (2014) had reported a MB based method, where a thiolated single-stranded
DNA was first assembled on to gold electrode. Complementary target DNA was then
hybridized with the lower part of the surface-bound probe to form an identical dstetranucleotide target sequence for both DNA adenine methylation (Dam) MTase and
methylation-resistant endonuclease Mbo I, then the upper part of the surface-bound probe
was hybridized with its complementary probes that attached with AuNPs, resulting in
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enormous AuNPs amplification units onto the electrode. Since AuNPs can accommodates
abundant MB and endounuclease Mbo I could not cleave the identical target sequence after it
was methylated by Dam MTase, resulting in increased voltammetric current. On the contrary,
the sequence without methylation could be cleaved, which would decrease the amount of
adsorbed MB, causing no current response.

3.1.4. Ligase chain reaction (LCR) based strategies
While PCR uses two sets of primers for amplification of DNA sequences, LCR adopts
four oligonucleotide probes along with thermostable ligases which are sensitive to
mismatches on the 3' end of a ligating DNA probe (Barany et al., 1991a, 1991b). Generally,
the readout part of target LCR products is obtained by optical methods or mass spectrometry
which are limited by high running cost and complex instrumentation of the sensing method
(Wee et al., 2013). In 2012, Wee et al coupled LCR with a simple and inexpensive
electrochemical readout method referred to as eLCR to detect single base mismatch (Wee et
al., 2012). By considering C to 5mC conversion as a single base change, Koo et al., (2014b)
extended this method to detect 5mC in a microdevice based electrochemical assay (Fig.3(iii)).
In this method, bisulfite converted and PCR amplified DNA target (where, C: methylated, T:
unmethylated) was further amplified by LCR with six probes (P1-P6) to analyze the
methylated DNA. In the first LCR cycle, probes complementary to C (P1) and probes
complementary to T (P5) ligated with probe P2. This P1/P5-P2 ligated probe then worked as
a template for further LCR amplification by P3, P4 and P6 probe. The exponential LCR
amplification produced two sets of ligated long knife motifs (one representing 5mC and the
other represents the unmethylated DNA). In contrast, the un-ligated probes produced short
knife motifs. These long and short knife motifs were then hybridized with P1 and P2 specific
capture probes, which were pre-immobilized onto two gold electrodes. These capture probles
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selectively captured methylated and unmethlated sequences respectively. DNAzymemediated electrocatalytic reduction of hydrogen peroxide (H2O2) at electrodes surfaces
resulted in the relative level of methylation at a particular CpG site. The applicability of this
assay was successfully tested in breast cancer cell lines and serum sample.
In order to detect heterogeneous methylation of epialleles of DNA strands (epialleles
are the DNA strands containing a mixture of methylated, unmethylated and partially
methylated regions), Wee et al., (2015b) developed an LCR based amplification method
coupled electrochemical readout referred to as ‘epiQ’. It has some unique advantages over
existing methodologies such as (i) it offers multiplexing in DNA methylation analysis, (ii) it
can quantify heterogeneous methylation of epialleles of DNA strands (epialleles are the DNA
strands containing a mixture of methylated, unmethylated and partially methylated regions).
Previously, NGS and digital PCR were commonly used to quantify the epialleles which are
limited by the high running cost and several multistep procedures. However, epiQ uniquely
offers an alternative to NGS and digital PCR to quantify heterogeneous methylation of
genomic DNA. In this approach, electrochemical microdevice was fabricated by
photolithography. Gold electrodes surface of the microdevice was functionalized with capture
probe via gold thiol self-assembling monolayer formation. Following LCR, biotin labelled
oligonucleotides (specific for respective epiallele sequences) were added with the LCR
products in different wells of the microdevice. After the addition of horseradish peroxidase
(HRP) in each well, electrocatalaytic reduction of H2O2 on the modified gold microelectrode
resulted in different CV response for different epialleles enabling the quantification of
heterogeneous DNA methylation. The applicability of the epiQ was successfully tested to
profile eight possible epialleles from CDKN2B (p15) tumor suppressor gene where it can
successfully distinguish 5% and 10% of differences in epiallele levels. The analytical
performance of the epiQ was also cross-validated with NGS.
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3.1.5. Photoelectrochemical-biosensing of DNA methylation
Generally, in photoelectrochemical approaches, a photoelectric transducers have been used to
convert the DNA recognition events into a significant electrical signals and such detection
mechanism relies on the recording of changed electrical signal of the employed photoactive
substances by the formation of DNA duplex or DNA-recognition elements complexes. (Wu
et al., 2013; Zhao et al., 2014). Compared to the conventional electrochemical readout
methods, it also offers higher sensitivity due to the reduced background noise (Zhao et al.,
2014). In 2008, a photoelectrochemical based strategy was developed to differentiate between
C and 5mC using the photosensitizer-injected hole transfer properties of DNA on gold
electrodes (Yamada et al., 2008). In this method, first, anthraquinone (AQ) photosensitizer
tagged oligodeoxynucleotide (ODN) duplexes containing 5mC or C were immobilized on
gold electrode. This AQ-ODN duplex DNA was then treated with methylation sensitive
restriction enzymes HapII or HhaI which cleaved unmethylated DNA strands leading to the
removal of photosensitizer unit from the gold electrode, thereby, reducing the photocurrent
density. On the contrary, in case of 5mC containing duplex, restriction enzyme did not cleave
the 5mC containing duplex retaining AQ which produced increased photocurrent density
(Fig. 3 (ii)).

Recently another photoelectrochemical method was reported for the analysis of DNA
methylation using Bi2S3 nanorods as photoelectric conversion material, and 6 × His and antihis tag antibody labeled recombinant methyl binding domain 1 (MBD1) protein as DNA
methylation recognizing unit (Yin et al., 2014). After CpG methylated probe hybridized with
its complementary and methylated CpG target probes on the Bi2S3 nanorods and AuNPsmodified electrode, the MBD1 protein was captured through the specifical interaction
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between MBD1 protein and symmetrical cytosine methylation in CpG region of dsDNA. Via
the immunoreaction between His tag at the end of MBD1 protein and anti-his tag antibody,
anti-his tag antibody was further captured on the electrode surface. Based on the
immobilization of MBD1 protein and antibody, the photoelectrochemical response decreased
significantly, which was used to detect methylated DNA. In this method, Bi2S3 nanorods
were used as photoelectric conversion material, MBD1 protein was used as DNA methylation
recognizing unit, anti-his tag antibody was used to further inhibit the photocurrent and
increase the detection sensitivity. Thus, it is limited by the use to antibody to achieve
amplified photoelectrochemical signal. A good photoactive materials having high photo to
current conversion efficiency could help to achieve sensitive DNA methylation sensor
without use of signal amplification element.

3.2. Electrochemical DNA methylation assays based on electroactive species
3.2.1. Semiconductors quantum dots (QDs) based assays
The opt-electrical characteristics, biocompatibility, sharp and well-resolved
voltametric peaks obtained from metal cation released from the QDs, make QDs as a
potential candidate for electroactive labeling in electrochemical DNA methylation assays
(Cui et al., 2007; Resch-Genger et al., 2008; Amelia et al., 2012). Moreover, the use of anodic
stripping voltammetry offers sharp stripping signals in QD-based assays, allowing sensitive
detection of target and render the opportunity of multiplexing (i.e., multiple QDs can be
incorporated in a single assay which can simultaneously be labelled with multiple targets for
their detection) (Zhang and Wang, 2012). Generally, QD based DNA methylation detection
assay is carried out by hybridizing the target DNA sequence with a surface-bound capture
probe (complementary to 5mC containing DNA sequences), which was then further
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recognized by a QD-tagged detection probe to obtain stripping voltammetric signals. For
example, Dai et al., (2013) developed a QD-based electrochemical readout method referred
to as E-msLDR (methylation-specific ligation-detection reaction) for the simultaneous and
multiplexed quantification of DNA methylation. In E-msLDR, two gene-specific methylation
loci of p53 gene was selected as a target and four locus-specific sequence probes were
designed, where probes 1 and 2 were labeled with QDs and probes 3 and 4 were coimmobilized magnetic bead. Bisulphite converted target gene was magnetically isolated from
the sample mixture via hybridization reaction between magnetic bead-attached capture probes
and target sequence followed by a magnetic isolation step. By further incubation of this
sample with QD-modified probes, the QD-modified magnetic beads were added to the E. coli
DNA ligase to initiate the LDR (ligation detection reaction) followed by a heating step at
90oC. When the target is methylated, the QD-modified probes perfectly matches the pretreated p53 gene and covalently interlined to form a stable duplex, in contrast. In case of the
unmethylated sample, the probes show single-base mismatch and cannot be ligated. By
performing voltametric analysis of QDs attached on the magnetic beads, the methylation
level of p53 gene fragment can be quantified (Fig. 4).

(Please insert Fig. 4 here)

Although E-msLDR avoids PCR amplification or restriction enzyme digestion, it is
limited by several hybridization and heating steps along with longer assay time. To avoid
these drawbacks, the same group has developed a modified method for quantifying
methylation level in p53 gene fragment using QD barcodes (Xu et al., 2016). In this method,
two dual-functional hairpin probes (HP) were designed and tagged with QDs. When target
5mC region reacted with QD-tagged HP HP loops were exposed allowing hybridization with
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targets. The target attached HPs were then magnetically isolated with another capture probefunctionalized magnetic beads. Stripping volatmmetric quantification of the QDs on isolated
beads was performed to quantify the level of methylation present in the target DNA. On the
other hand, when target DNA was unmethylated, HP loops will not open causing no
hybridization among target and magnetic beads, resulting no stripping signals.

3.2.2. Electrochemically active ligands based methods
In recent years, a number of electroactive ligands or molecules (e.g., methylene blue,
triphenylmethane, etc.) have been used in developing various electrochemical methylation
assays (Dai et al., 2012; Sato et al., 2010, Tanaka et al., 2007). In 2007, Okamoto and
colleagues reported a bisulfite-free and PCR-free method for the detection of DNA
methylation using a tag-attachable bipyridine electroactive ligand. A bipyridine derivative
with a tag-attachable amino linker at C4 position was initially synthesized which was then
used to directly complexed with 5mC residue in a reaction mixture containing potassium
osmate and potassium hexacyanoferrate (III). The succinimidyl esters of functional labeling
units were then attached to the bipyridine ligand fixed on the 5mC. This allows them to detect
the target 5mC in DNA electrochemically, where a capture probe attached electrode was used
to selective hybridized the target, and read the methylation level via SWV. Faradic
impedance spectroscopic readout in the presence of [Fe(CN)6]3-/4- has also been used in this
system to detect 5mC, where the ligand attached-5mC showed a relatively higher interfacial
electron-transfer resistance compare to those obtained at the unmethylated and non-target
samples.
Sato and colleagues explored the use of ferrocenylnaphthalene diimide (FND)
derivatives in detecting 5mC (Sato et al., 2006, 2010, 2012, 2014). These derivatives can
intercalate into dsDNA by a threading intercalation mode at every two base pairs, resulting in
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the arrangement of many ferrocene molecules in the major and minor grooves of dsDNA.
This would offer a significant enhancement in electrochemical signal (Sato et al., 2010,
2012). In 2006, they demonstrated that use of FND in 5mC detection improves the
electrochemical response by stabilizing the dsDNA and producing more charge transfer
through dsDNA (i.e., duplex-mediated charge transport). In this method, a 20bp long
methylated promoter region of p16Ink4a gene containing two 5mC at the 3' end of the
sequence was selected as target. After bisulfite treatment, target region of gene was amplified
by the PCR with the methylation-specific primers. The PCR-amplified samples were then
hybridized with two DNA probes pre-immobilised on to a chip array containing 25 gold
electrodes. During hybridization, methylated specific probe was fully matched with
methylated sequence, whereas other showed mismatch with it. Under optimal conditions,
both probes formed duplexes with the target DNA sequence. However, mismatched duplex
would be less stable compared to the matched duplex containing 5mC. This was detected by
measuring the voltammetric currents in the presence of FND complexes, where matched
duplex DNA produced significantly larger current in compare to that of the mismatched
duplex. This method was further extended to detect methylation of CDH4 and hTERT genes
(Sato et al., 2010; Sato et al., 2014). Although, these FND-based electrochemical
hybridization methods showed their significant potential in detecting 5mC, they need prior
knowledge of the target DNA sequences, and therefore is not suitable for the analysis of
samples containing unknown sequences.
As discussed briefly in Section 3, methylene blue is one of the widely used
electroactive indicators for the analysis of various types of DNA targets including DNA
methylation, point mutation and DNA lesion (Boon et al., 2000; Kelley et al., 1999; Jing et
al., 2014). Generally, in methylation assays, MB attach either intercalatively to the hybridized
dsDNA or covalently to the reporter probes (Dai et al., 2012; Hou et al., 2003; Jing et al.,
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2014). Among other electroactive redox molecules, [Ru(NH3)6]3+ has also been used in
electrochemical methylation assays. Wang et al., (2012) has developed an electrochemical
assay for DNA methylation analysis of p53 gene containing two CpG sites (Wang et al.,
2012). In this assay, the bisulfite-treated target gene was hybridized with a complimentary
peptide nucleic acid (PNA) probe pre-immobilized onto an AuNPs-modified GCE. When
target is fully methylated, it completely hybridized with the surface-bound PNA probe
making a duplex. [Ru(NH3)6]3 then electrostatically attached to the negatively charged
backbone of p53, making a PNA-methylated p53-[Ru(NH3)6]3 complex, which produced
enhanced voltammetric current. However , if the p53 is unmethylated, two C converted to U
via bisulfite treatment, resulting two bases mismatches with the PNA probe. Thus, the a
PNA-unmethylated p53-[Ru(NH3)6]3 hybridization efficiency becomes relatively low which
resulted less voltammetric current.

3.3. Electrochemical detection of DNA methylation based on affinity interaction of DNA
nucleobases

3.3.1. Gold-DNA affinity interaction based method
The adsorption between gold and “native” DNA has been regarded as ‘complex’,
‘non-specific’ and ‘difficult to control’. Mirkin and Rothberg groups have performed several
key experimental and fundamental studies and reported that adsorption of DNA towards gold
is sequence dependent and follows a definite adsorption trend of adenine (A) > cytosine (C)>
guanine (G) > thymine (T) (Demers et al., 2000; Demers et al., 2002; Kimura-Suda et al.,
2003; Li and Rothberg, 2004; Ostblom et al., 2005; Zhang et al., 2012). Since then base
dependent DNA adsorption emerged as one the most promising solutions to achieve
controlled immobilization of unmodified DNA probes onto gold surfaces. Because this
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adsorption is highly sequence (base) dependent, it can also be used to distinguish two
different DNA sequences (e.g., bisulphite treated sequences representing methylated and
unmethylated DNA. However, this phenomenon has not been taken into consideration to
analyze DNA methylation until 2014. In 2014, Sina et al. (2014b) reported an
electrochemical method for quantifying 5mC using different affinity interaction between
DNA bases and unmodified gold electrodesreferred to as eMethylsorb (Fig. 5 (i)). In
eMethylsorb, after bisulfite treatment and asymmetric PCR amplification steps, target
methylated DNA become guanine-enriched, while unmethylated sample become adenine
enriched. Since DNA–gold affinity interaction follows the trend, A > C > G >T the adenineenriched unmethylated DNA leads to a larger level of adsorbed DNA on the electrode in
comparison to the guanine-enriched methylated DNA. This provides less Faradaic current
due to the strong coulombic repulsion between [Fe(CN)6]3- and negatively charged adenine
enriched DNA strands. This method has been used to distinguish methylated and
unmethylated epigenotypes at single CpG resolution.

3.3.2. Graphene-DNA affinity interaction based method
More recently, Hakim et al. (2016) developed a unique electrochemical method for
the quantification of methylation level in samples taken from oesophageal cancer tissues. The
underlying principle of this method was the different affinity interaction between DNA bases
and graphene surface. The different affinity interaction can be explained by considering the
polarisabilities of the individual nucleobases. Among all nucleobases, G and A with their
five- and six-membered rings possess the largest polarisabilities, whereas other bases with
only six-membered rings exhibit lower polarisabilities. Additionally, G with its doublebonded oxygen atom possess a larger polarisability than A. Since the van der Wall (vdW)
energy is directly proportional to the interacting nucleobases, Scheicher (Gowtham et al.,
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2007) and Rao (Varghese et al., 2009) proposed that vdW interaction is indeed the main
driving force for the adsorption of nucleobases onto the graphene and follows the adsorption
trend as G> A> T> C. Bisulfite converted and G-enriched sequences are directly adsorbed on
the graphene modified electrode, which leads to a larger amount of the adsorption on to the
electrode in comparison to the A-enriched unmethylated DNA. Therefore, methylated DNA
will give less electrochemical readout (due to more adsorption of guanine on graphene
modified electrode) compared to unmethylated DNA. They successfully tested the method in
a panel of cancer cell lines and patient samples derived from oesophageal squamous cell
carcinoma to detect FAM134B promoter gene methylation.
The simplicity and functionality of affinity interaction based methods involve (i) the
use of differential adsorption affinity of DNA nucleotides as a tool for cancer biomarker
detection, (ii) adoption of a simple and inexpensive read-out (i.e., electrochemistry), (iii)
demonstration of an simple and rapid detection method without the use of complicated
surface modifications, and (iv) potential multiplexing capability. Since the this approach
distinguishes between methylated and unmethylated DNA depending on the base changes
generated at the CpG sites by bisulphite treatment, they assumed that that it may also find its
application in detecting global hypomethylation.
3.4. Methylation assay using carbon based electrodes
There has been an increasing interest on using carbon based working electrodes in the
electrochemical assay for detecting DNA methylation. Several studies have been carried out
to detect 5mC on nanocarbon-film electrodes by optimizing the assay condition and surface
modification of the electrode (Goto et al., 2010; Kato et al., 2008; Yanagisawa et al., 2015).
It has been shown that assay performance of nanocarbon-film electrode based strategies are
highly relied on the physical properties of the electrodes and their functionalization. More
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recently, carbon based GCE and screen-printed electrodes have also been successfully
modified with conducting polymer, carbon nanotubes, nanocomposite and nanostructured
gold materials used to analyze DNA methylation (Wang et al., 2016b; Zhu et al., 2015; Wang
et al., 2013; Serpi et al., 2013; Zhu et al., 2015; Daneshpour et al., 2016; He et al., 2011). For
example, Daneshpour et al., (2016) chemically modified screen printed carbon electrode
surfaces with Fe3O4/N-trimethyl chitosan/gold nanocomposite and polythiophene to quantify
5mC in a RASSF1A tumor suppressor gene. In this method, the nanocomposite
Fe2O3/TMC/Au works as tracing label of the DNA probe which increases the electrochemical
readout by several fold due to the presence of AuNPs.
4. Conclusions and perspective
We have reviewed the current electrochemical strategies for DNA methylation
analysis. We have also pointed out the methodological shortcomings of these strategies. The
diagnostic and prognostic significance of 5mC have also been discussed. The importance of
direct detection of 5mC either by oxidizing the nucleobases or by directly adsorbing the
target onto the gold or graphene electrodes, which could significantly simply the assay
fabrication by avoiding the multistep surface functionalization process, has also been
discussed. It is now apparent that many traditional electrode have been modified with various
nanomaterials to achieve improved analytical performance. It is also apparent that most of the
methylation detection methods described here have been developed as a proof of concept
study. They are yet to be tested how they perform in real, heterogeneous clinical samples
which are far more complex and difficult to analyse. However, the advent of the recent
breakthroughs in electrochemical detection approaches for DNA methylation is a reflection
of intense focus and endeavor of the researchers in this field.
Though electrochemical sensors have potential to be used as a point-of-care tool in
clinics for DNA methylation analysis, significant challenges are still required to be addressed
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before they can be used in clinics. We believe that a fully automated electrochemical sensor
that can work with no human intervention is required for their routine methylation analysis
studies in clinics. Furthermore, innovative and real-time sampling strategies are needed to
avoid false negative bias (i.e., small volume of blood taken from a cancer patient may not
carry the necessary methylation markers and will result in a false negative result). Though
there are major challenges which need to be addressed, we foresee that in near future these
proof-of-concept studies will be translated in both clinical and research platforms for
analyzing DNA methylation.
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Figure Captions

Fig. 1. DNA methylation and its association with tumorigenesis. (i) Representation of the
transfer of a methyl group to naked DNA by Dnmt3a and Dnmt3b, while Dnmt1 upholds the
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DNA methylation pattern during semiconservative replication. (ii) Representation of the
changes in methylation in early periods of tumorigenesis. Reproduced from Moore et al.
(2013) and Robertson (2005) with permission from Nature Publishing Group.

Fig. 2. Direct electrochemical oxidation of 5mC. (i) Individual nucleobases and 5mC were
cut by restriction endonuclease followed by their oxidation which produced distinct oxidation
peak for 5mC and C. (ii) Background-subtracted differential pulse voltametric responses from
the direct oxidation of bases where 50 mM 5mC (A) and 50 mM C (B) 50 mM 5mC and C
(C) 25 mM G and A, and 50 mM 5mC and C (D) were used to differentiate 5mC from C. (a)(d) represents the fabrication steps of the electrode where bare (a) GCE, (b) Ch/GCE, (c)
MWNTs/GCE and (d) MWNTs/Ch/GCE were used. Reproduced from Kato et al. (2011) and
Wang et al. (2010) with permission from with permission from The American Chemical
Society and The Royal Society of Chemistry, respectively.

Fig. 3 Enzymatic reaction and amplification based electrochemical DNA methylation assays.
(i) Signal-on assay, where unmethylated and methylated DNA produced two distinct redox
signals in CV resulting in the activity analysis of MTase (as the different pattern of MTase
activity is directly related to the distinct current changes in CV), (ii) Representation of
photoelectrochemical discrimination of C and 5mC in DNA immobilized on a gold electrode
and (iii) Ligase chain reaction based electrochemical assay for the detection of 5mC. Figures
(i), (ii) and (iii) are reproduced from Muren et al. (2013), Yamada et al. (2008) and Koo et al.
(2014) with permission from The American Chemical Society, Royal Society of Chemistry,
and Elsevier, respectively.
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Fig. 4. Schematic representations of methylation-specific ligation-detection reaction based
assay for the simultaneous electrochemical detection of multiple gene-methylation loci.
Reproduced from Dai et al., 2013 with permission from The Royal Society of Chemistry.

Fig. 5. Schematic of the eMethylsorb and graphene-DNA based methylation assays.
Bisulphite conversion and PCR amplification processes converted methylated and
unmethylated sequences sample into guanine- and adenine-enriched sequences. (i) Since
DNA–gold affinity interaction follows the trend, A>C>G> T, the adenine-enriched
unmethylated DNA leads to a larger level of adsorbed DNA on the electrode in comparison
to the guanine-enriched methylated DNA. This provides less relative current for
unmethylated sample due to the strong coulombic repulsion between [Fe(CN)6]3- and
negatively charged adenine-enriched DNA strands.(ii) Since graphene –gold affinity
interaction follows the trend, G>A>C>T, the guanine-enriched methylated DNA leads to a
larger level of adsorbed DNA on the electrode in comparison to the adenine-enriched
unmethylated DNA, resulting less relative current for methylated sample. Figures (i) and (ii)
reproduced from Sina et al. (2014b) and Haque et al., (2016) with permission from The
American Chemical Society and Elsevier, respectively.
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